for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

PerkinElmer, Inc.

PKI

Latest Trade

84.10USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

71.83

 - 

103.00

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
84.10
Open
--
Volume
--
3M AVG Volume
15.17
Today's High
--
Today's Low
--
52 Week High
103.00
52 Week Low
71.83
Shares Out (MIL)
111.08
Market Cap (MIL)
9,230.43
Forward P/E
20.59
Dividend (Yield %)
0.34

Next Event

Q3 2019 PerkinElmer Inc Earnings Release

Latest Developments

More

Perkinelmer Launches PG-Seq Rapid Non-Invasive Preimplantation Genetic Testing Kit

Perkinelmer Issued $850 Mln Aggregate Principal Amount Of 3.300% Senior Notes Due 2029

Perkinelmer Prices Offering Of Senior Notes

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About PerkinElmer, Inc.

PerkinElmer, Inc. is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets. It provides analytical instrumentation for the industrial market, which includes the chemical, electronics, energy, lubricant, petrochemical and polymer industries. Its products include AAnalyst, Altus, Aquamatic, Avio, AxION, Clarus, DairyGuard, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, Cell carrier and cell::explorer. The Diagnostics segment is focused on reproductive health, emerging market diagnostics and applied genomics. Its products include AutoDELFIA, BACS-on-Beads, Bioo Scientific, BoBs, Datalytix, Dexela, Dexela CMOS FPDs, Evolution, ViaCord, and Zephyr.

Industry

Scientific & Technical Instr.

Contact Info

940 Winter St

+1.781.6635776

http://www.perkinelmer.com/

Executive Leadership

Robert F. Friel

Chairman of the Board, Chief Executive Officer

Prahlad R. Singh

President, Chief Operating Officer, Director

James M. Mock

Chief Financial Officer, Senior Vice President

Deborah Butters

Chief Human Resource Officer, Senior Vice President

Joel S. Goldberg

Senior Vice President - Administration, General Counsel, Secretary

Key Stats

2.46 mean rating - 13 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

2.1K

2017

2.3K

2018

2.8K

2019(E)

2.9K
EPS (USD)

2016

2.600

2017

2.900

2018

3.610

2019(E)

4.035
Price To Earnings (TTM)
37.18
Price To Sales (TTM)
3.29
Price To Book (MRQ)
3.41
Price To Cash Flow (TTM)
20.72
Total Debt To Equity (MRQ)
78.05
LT Debt To Equity (MRQ)
77.75
Return on Investment (TTM)
4.56
Return on Equity (TTM)
4.04

Latest News

Latest News

UPDATE 1-PerkinElmer raises 2018 forecasts as 1st-qtr profit beats Street

Laboratory equipment maker PerkinElmer posted a slightly higher-than-expected first-quarter profit on Monday and revised its full-year earnings forecast upward as sales grew in both of its business units.

PerkinElmer first-quarter profit beats Street view

Laboratory equipment maker PerkinElmer on Monday reported slightly higher-than-expected first-quarter profit and revenue and raised its full-year earnings forecast as sales grew in both of its business units.

BRIEF-PerkinElmer Appoints James Mock As Chief Financial Officer

* PERKINELMER INC - ANDY WILSON WILL REMAIN WITH COMPANY AS AN ADVISOR FOR AN INTERIM PERIOD Source text for Eikon: Further company coverage:

BRIEF-PerkinElmer Collaborates With Helix In Exome Based Personal Genomics

* PERKINELMER COLLABORATES WITH HELIX TO DRIVE INNOVATION IN EXOME-BASED PERSONAL GENOMICS

BRIEF-Perkinelmer Inc Files Prospectus Supplement Related To A Potential Senior Notes Offering

* PERKINELMER INC FILES PROSPECTUS SUPPLEMENT RELATED TO A POTENTIAL SENIOR NOTES OFFERING - SEC FILING Source text: (https://bit.ly/2q3PNq6) Further company coverage:

BRIEF-RHS Enters Deal For Perkinelmer, Inc To Buy All Shares Of Co For $0.28 Per Share

* ENTERS SCHEME IMPLEMENTATION AGREEMENT FOR PERKINELMER, INC TO BUY ALL SHARES OF CO FOR $0.28 PER SHARE

BRIEF-Perkinelmer Reports Q4 GAAP Loss Per Share From Cont Ops of $0.35

* Q4 ADJUSTED EARNINGS PER SHARE FROM CONTINUING OPERATIONS $0.97

PerkinElmer profit, 2018 forecast top Wall Street estimates

Laboratory equipment maker PerkinElmer Inc <PKI.N> on Thursday reported higher-than-expected fourth quarter sales and profit and issued an initial 2018 earnings forecast that surpassed Wall Street estimates.

PerkinElmer profit, 2018 forecast top Wall Street estimates

Laboratory equipment maker PerkinElmer Inc on Thursday reported higher-than-expected fourth quarter sales and profit and issued an initial 2018 earnings forecast that surpassed Wall Street estimates.

BRIEF-Perkinelmer Q4 Adjusted Earnings Per Share $0.97 From Continuing Operations

* PERKINELMER ANNOUNCES FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL YEAR 2017

BRIEF-Perkinelmer Inc reports Q3 adjusted earnings per share $0.73

* Perkinelmer Inc announces financial results for the third quarter of 2017

UPDATE 1-PerkinElmer third quarter profit edges past Street forecast

Laboratory equipment maker PerkinElmer Inc on Thursday reported slightly better-than-expected third-quarter profit and revenue and narrowed its full-year earnings forecast range while keeping the midpoint the same.

PerkinElmer third quarter profit edges past Street forecast

Laboratory equipment maker PerkinElmer Inc <PKI.N> on Thursday reported slightly better-than-expected third-quarter profit and revenue and narrowed its full-year earnings forecast range while keeping the midpoint the same.

PerkinElmer picks patent fight with Alere over blood testing kits

Scientific instrument maker PerkinElmer Inc on Monday filed a patent infringement lawsuit against diagnostic testing company Alere Inc, a subsidiary of health care giant Abbott Laboratories.

BRIEF-PerkinElmer ‍announced upcoming retirement of Andy Wilson CFO

* PerkinElmer Inc - Announced upcoming retirement of Andy Wilson, senior vice president and chief financial officer

BRIEF-PerkinElmer launches QSight210 MD system for clinical laboratories

* PerkinElmer Inc - launches QSight210 MD system for clinical laboratories Source text for Eikon: Further company coverage:

BRIEF-PerkinElmer enters into 364-day unsecured term loan facility

* PerkinElmer Inc - on August 11, entered into a 364-day unsecured term loan facility in principal amount of $200 million - SEC filing

REFILE-BRIEF-PerkinElmer launches clinical whole genome sequencing services

* PerkinElmer launches clinical whole genome sequencing services

PerkinElmer profit meets Street view, boosts 2017 forecast range

Scientific instruments maker PerkinElmer Inc <PKI.N> on Thursday posted a second-quarter profit that matched expectations and boosted its full-year earnings forecast range with a new midpoint slightly ahead of Wall Street estimates.

BRIEF-PerkinElmer reports Q2 GAAP EPS from continuing operations $0.57

* Q2 GAAP earnings per share from continuing operations $0.57; Q2 adjusted earnings per share $0.67; Q2 GAAP revenue $547.0 million versus $536.2 million

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up